Is Alnylam Pharmaceuticals (ALNY) Stock Outpacing Its Medical Peers This Year?Zacks Investment Research • 11/18/25
Alnylam Pharmaceuticals, Inc. (ALNY) Presents at UBS Global Healthcare Conference 2025 TranscriptSeeking Alpha • 11/10/25
New Post Hoc Analysis from the HELIOS-B Phase 3 Study Shows Vutrisiran Improved Measures of Heart Structure and Function in Patients with ATTR-CMBusiness Wire • 11/08/25
American Century Focused Dynamic Growth Fund Q3 2025 Performance Contributors And DetractorsSeeking Alpha • 11/05/25
Biotech is back. Here's why these rallying stocks belong in your portfolio now.Market Watch • 11/03/25
Alnylam Pharmaceuticals: Q3 Earnings Review - A Sensational Year Reaches Its PeakSeeking Alpha • 10/31/25
ALNY Q3 Earnings and Revenues Top Estimates on Higher Amvuttra SalesZacks Investment Research • 10/31/25
Alnylam Stock Has Already Doubled In 2025. Why It Could Rocket Again On Earnings.Investors Business Daily • 10/30/25
Alnylam Pharmaceuticals Reports Third Quarter 2025 Financial Results and Highlights Recent Period ProgressBusiness Wire • 10/30/25
Exploring Analyst Estimates for Alnylam (ALNY) Q3 Earnings, Beyond Revenue and EPSZacks Investment Research • 10/28/25
S&P 500's New AI Play? Walmart In Buy Zone, Leads Five Stocks To Watch Amid Volatile MarketInvestors Business Daily • 10/18/25
Alnylam to Webcast Conference Call Discussing Third Quarter 2025 Financial ResultsBusiness Wire • 10/16/25
Are You Looking for a Top Momentum Pick? Why Alnylam Pharmaceuticals (ALNY) is a Great ChoiceZacks Investment Research • 10/15/25
Here's Why Alnylam Pharmaceuticals (ALNY) is a Strong Momentum StockZacks Investment Research • 10/14/25
Is Alnylam Pharmaceuticals (ALNY) Outperforming Other Medical Stocks This Year?Zacks Investment Research • 10/14/25
Alnylam Announces First Patient Dosed in ZENITH Global Phase 3 Cardiovascular Outcomes Trial of ZilebesiranBusiness Wire • 10/01/25
New Data from HELIOS-B Phase 3 Study Demonstrate Lower Rates of Gastrointestinal Events in ATTR-CM Patients Treated with VutrisiranBusiness Wire • 09/28/25
Alnylam Pharmaceuticals, Inc. (ALNY) Presents at Bernstein Insights: Healthcare Leaders and Disruptors - 2nd Annual Healthcare Forum TranscriptSeeking Alpha • 09/23/25
Alnylam Pharmaceuticals joins Alliance for Genomic Discovery, expanding diverse clinical genomic dataset to drive precision medicinePRNewsWire • 09/18/25